Evaluation of the immunotoxicity and allergenicity of a new intranasal influenza vector vaccine against tuberculosis carrying TB10.4 and HspX antigens

OBJECTIVE(S): A new vaccine candidate TB/FLU-05E has been developed at the Smorodintsev Research Institute of Influenza (Russia). The vaccine is based on the attenuated influenza strain A/PR8/NS124-TB10.4-2A-HspX that expresses mycobacterial antigens TB10.4 and HspX. This article describes the resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Stosman, Kira I., Aleksandrov, Andrey G., Sivak, Konstantin V., Buzitskaya, Zhanna V., Stukova, Marina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083829/
https://www.ncbi.nlm.nih.gov/pubmed/37051099
http://dx.doi.org/10.22038/IJBMS.2023.68440.14936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083829/
https://www.ncbi.nlm.nih.gov/pubmed/37051099
http://dx.doi.org/10.22038/IJBMS.2023.68440.14936

Ejemplares similares